Gallery
Public Outreach
OncoLogics: When cancer treatment becomes logical
Video for European Partnership for Personalised Medicine
EP PerMed Conference 2025
Colorectal cancer remains a major health challenge. Despite treatment advances, late-stage survival is low. Our project, ONCOLOGICS, combines computer and lab models to better understand patient-specific drug responses and guide treatment. By simulating cancer progression and testing therapies on lab-grown tumor models, we aim to identify the most effective options faster. Our diverse team—spanning biology, medicine, tech, and ethics—works across Europe to make cancer treatment more precise. Though challenges remain, this platform shows the potential of combining simulations with experiments to support clinical decisions and improve outcomes for patients with colorectal cancer.
Interview with Eirini Tsirvouli
Video for European Partnership for Personalised Medicine
EP PerMed Conference 2025
Eirini Tsirvouli from the Norwegian University of Science and Technology was honored as the winner of the EP PerMed Video Competition for Young Investigators. As part of the ONCOLOGICS consortium (funded under ERA PerMed JTC2020), Tsirvouli and her colleagues wanted to move away from a 'one size fits all' approach. Based on the unique genotypic and phenotypic characteristics of each tumour, they worked to develop a computational modelling platform to support decision-making in personalised clinical therapy for colorectal cancer. In our interview, Eirini talks about the challenge of explaining years of research in a two-minute video that the general public can understand, and how this change of perspective can help you understand your own research better.